Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Makoto Nakamuta

Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure

scientific article

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

scientific article published on 28 August 2019

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan

scientific article published on 02 January 2019

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan

scientific article published on 09 August 2019

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

scientific article published on 28 November 2019

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan

scientific article published on 16 January 2020

Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors

scientific article published on 01 September 2008

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study

scientific article published on 08 September 2020

Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection

scientific article published on 14 October 2019

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan

scientific article published on 08 March 2019

The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

scientific article published on 03 March 2020

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study

scientific article published on 14 March 2019

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

scientific article published on 15 April 2019

Paulina is supported by:

About Paulina

Help